{
  "case_id": "MN21-36414",
  "year": 2021,
  "patient_info": {
    "age_range": "51 to 64",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "Lupkynis",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "FDA approved for refractory nephritis"
    }
  ],
  "treatments_tried_but_failed": [
    {
      "name": "Prednisone",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Mycophenolate Mofetil",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Cyclophosphamide",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Hydroxychloroquine",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": null,
  "guidelines_details": "Lupkynis is FDA approved for refractory nephritis.",
  "soc_support": true,
  "soc_not_support": null,
  "soc_details": "Treatment with Lupkynis is appropriate for management of lupus nephritis after failure of standard therapies.",
  "study_support": true,
  "study_details": [
    {
      "study_name": "Rovin, et al.; Clarke",
      "study_authors": "Rovin, et al.; Clarke",
      "key_findings": "Lupkynis is appropriate for management of lupus nephritis after failure of standard therapies."
    }
  ],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": true,
  "rationale": "The requested Lupkynis (voclosporin) 7.9 mg capsules are medically necessary for treatment of this patient due to failure of multiple standard first-line therapies.",
  "reviewer_credentials": "Board certified in internal medicine with subspecialty certification in nephrology, actively practicing, expert in treatment of lupus nephritis."
}